Search

Displaying results 3341 - 3350 of 10000 in total
  1. Drug

    Anrikefon

    go.drugbank.com/drugs/DB21529
    Investigational

    Anrikefon is a small molecule drug. Anrikefon has a monoisotopic molecular weight of 703.44 Da.

  2. Drug

    Lefleuganan

    go.drugbank.com/drugs/DB21533
    Experimental

    Lefleuganan is a small molecule drug. Lefleuganan has a monoisotopic molecular weight of 1179.78 Da.

  3. Drug

    Orziloben

    go.drugbank.com/drugs/DB21653
    Experimental

    Orziloben is a small molecule drug. Orziloben has a monoisotopic molecular weight of 222.13 Da.

  4. Drug

    Tegeprotafib

    go.drugbank.com/drugs/DB21665
    Experimental

    Tegeprotafib is a small molecule drug. Tegeprotafib has a monoisotopic molecular weight of 326.04 Da.

  5. Drug

    Vamagloxistat

    go.drugbank.com/drugs/DB21666
    Experimental

    Vamagloxistat is a small molecule drug. Vamagloxistat has a monoisotopic molecular weight of 371.11 Da.

  6. Drug

    Milpecitinib

    go.drugbank.com/drugs/DB21676
    Experimental

    Milpecitinib is a small molecule drug. Milpecitinib has a monoisotopic molecular weight of 380.13 Da.

  7. Drug

    Claziprotamide

    go.drugbank.com/drugs/DB21687
    Experimental

    Claziprotamide is a small molecule drug. Claziprotamide has a monoisotopic molecular weight of 374.13 Da.

  8. Drug

    Fluorometholone

    go.drugbank.com/drugs/DB00324
    ApprovedInvestigational

    A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders.

  9. Drug

    Montmorillonite

    go.drugbank.com/drugs/DB13654
    Investigational

    Mixtures: Dr. SEED Teatree and Lime Vegan No-sebum Cool Anti HairlossShampooCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Gefitinib

    go.drugbank.com/drugs/DB00317
    ApprovedInvestigational

    Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa. … Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer.